Our own future research is underway with whole genome sequencing to study the risk of these polymorphisms and potentially more undiscovered IL6 polymorphisms contributing to the risk of developing SSc, with or without ILD, and IPF. The gene discussed is IL6; the disease is systemic sclerosis.